- Home
- OUT vs CDTX Comparison
OUT vs CDTX Comparison
Compare OUT & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUT
- CDTX
- Stock Information
- Founded
- OUT 2013
- CDTX 2012
- Country
- OUT United States
- CDTX United States
- Employees
- OUT N/A
- CDTX N/A
- Industry
- OUT Real Estate Investment Trusts
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OUT Real Estate
- CDTX Health Care
- Exchange
- OUT Nasdaq
- CDTX Nasdaq
- Market Cap
- OUT 3.2B
- CDTX 2.8B
- IPO Year
- OUT N/A
- CDTX 2015
- Fundamental
- Price
- OUT $20.05
- CDTX $101.82
- Analyst Decision
- OUT Buy
- CDTX Strong Buy
- Analyst Count
- OUT 6
- CDTX 13
- Target Price
- OUT $19.44
- CDTX $118.50
- AVG Volume (30 Days)
- OUT 1.3M
- CDTX 867.5K
- Earning Date
- OUT 11-06-2025
- CDTX 11-06-2025
- Dividend Yield
- OUT 6.81%
- CDTX N/A
- EPS Growth
- OUT N/A
- CDTX N/A
- EPS
- OUT 0.60
- CDTX N/A
- Revenue
- OUT $1,796,000,000.00
- CDTX N/A
- Revenue This Year
- OUT N/A
- CDTX N/A
- Revenue Next Year
- OUT $2.79
- CDTX N/A
- P/E Ratio
- OUT $29.36
- CDTX N/A
- Revenue Growth
- OUT N/A
- CDTX N/A
- 52 Week Low
- OUT $12.95
- CDTX $12.74
- 52 Week High
- OUT $19.98
- CDTX $121.21
- Technical
- Relative Strength Index (RSI)
- OUT 71.06
- CDTX 53.42
- Support Level
- OUT $17.40
- CDTX $95.73
- Resistance Level
- OUT $17.82
- CDTX $113.00
- Average True Range (ATR)
- OUT 0.59
- CDTX 6.30
- MACD
- OUT 0.16
- CDTX -1.49
- Stochastic Oscillator
- OUT 96.77
- CDTX 41.03
About OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.